Navigation Links
Canadian Research Well Represented at HIV Prevention Conference
Date:10/27/2014

WINNIPEG, Oct. 27, 2014 /CNW/ - A robust contingent of Canadian researchers will present their work this week at the HIV Research for Prevention (HIV R4P) Conference in Cape Town, South Africa.

The conference to be held from Oct. 28 to 31 is expected to attract up to 1,500 global leaders in HIV prevention, research, programs and policy. HIV R4P is the world's first and only scientific meeting dedicated exclusively to biomedical HIV prevention research.

Twenty nine oral and poster presentations will be made by Canadian researchers, 10 of whom received scholarships from the conference to present their work at HIV R4P. Presentation topics include: subject selection in HIV vaccine trials; the role of hormones in natural protection against HIV-1 in the Kenyan HIV-exposed seronegative cohort; and gay men involved in HIV — their concerns and hopes about pre-exposure prophylaxis (PrEP).

"The sample of Canadian research at HIV R4P is something we can celebrate," says Dr. Allan Ronald, senior scientific advisor of the Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO). "It is also a testament to the ongoing international collaborations Canadian investigators have with researchers in other countries."

Among the Canadian presenters is Dr. Ken Rosenthal, a large team grant principal investigator whose work on innate, adaptive, and mucosal immune responses in HIV-1 exposed uninfected infants in South Africa is funded through the CHVI.

"The HIV R4P Conference is essentially looking at research for prevention, and Canada really has an important role to play in bringing HIV under control," says Rosenthal, who is also the first Visiting Scientist at the Cape Town HIV Vaccine Trials Network (HVTN) Immunology Laboratory. The state-of-the-art South African HIV vaccine research facility is supported by the Hutchinson Center Research Institute of South Africa (HCRISA), and funding for the laboratory's recent renovation was received from the Bill & Melinda Gates Foundation through the CHVI.

"The CHVI really is a driver for a number of reasons," Rosenthal says. "It builds linkages with investigators in developing countries which opens doors for Canadian research collaborations with colleagues in a global fashion."

Ronald adds that the CHVI has achieved some important outcomes since it started in 2007. "It has assisted with building regulatory capacity in low and middle-income countries, secured funding with the Canadian Institutes of Health Research (CIHR) and the Department of Foreign Affairs, Trade and Development (DFATD) for five collaborative scientific teams of Canadians with African colleagues, and facilitated with the Canadian private sector advances in the development of an HIV vaccine," he says.

The CHVI brings together five Government of Canada Departments/Agencies and the Bill & Melinda Gates Foundation to advance progress on HIV vaccine research and development efforts. It also contributes to the prevention of mother-to-child transmission. The establishment of the ACO at the International Centre of Infectious Diseases in Winnipeg in 2011 has facilitated information exchange, collaboration and coordination across diverse national and international research efforts.  


'/>"/>
SOURCE Alliance Coordinating Office
Copyright©2014 PR Newswire.
All rights reserved

Related biology news :

1. Recreational activity a major pollutant on Canadian coast of Pacific Ocean
2. Pyrocumulonibus cloud rises up from Canadian wildfires
3. Smoke from Canadian wildfires over Baffin Bay
4. Smoke from Canadian fires hover over Great Lakes
5. NOAAs GOES-West satellite sees smoke from Canadian fires over US
6. Canadian physicians lack knowledge and confidence about breastfeeding
7. New database features 710,000 natural history records from Canadian Museum of Nature
8. U of T report finds millions of Canadians still struggle to afford food
9. Fewer than 1 in 10 Canadians in ideal cardiovascular health
10. Canadian researchers lead groundbreaking discovery in deadly childhood cancer
11. Life Technologies Collaborates with Canadian Centre for DNA Barcoding on Species Biodiversity Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , March 1, 2017  Aware, Inc. (NASDAQ: AWRE), ... that Richard P. Moberg has resigned, effective ... and Chief Financial Officer and Treasurer of Aware citing ... serve as a member of the Board of Directors ... Aware,s co-Chief Executive Officer and co-President, General Counsel has ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... 23, 2017 , ... Advanced Polymer Monitoring Technologies (APMT), a ... “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd will lead ... Floyd’s career has spanned 30 years in the chemicals and equipment industries. Sig ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
Breaking Biology Technology: